Intensity modulated radiation therapy (IMRT) for the treatment of unicentric Castlemans disease: a case report and review of the use of radiotherapy in the literature
Open Access
- 1 January 2012
- journal article
- review article
- Published by Walter de Gruyter GmbH in Radiology and Oncology
- Vol. 46 (3), 265-70
- https://doi.org/10.2478/v10019-012-0008-0
Abstract
Surgical resection is considered standard therapy for cases of resectable unicentric Castleman's disease (UCD). Unresectable cases of UCD do not have a consensus regarding the optimal treatment approach, but have utilized steroids, observation, chemotherapy, and radiotherapy. Here we discuss a patient presentation of UCD treated with an advanced radiotherapy technique, IMRT. A 47 year old female was found to have an intra-thoracic posterior UCD and was determined not to be a good surgical candidate. She was referred for radiotherapy and was treated using IMRT to a total dose of 4320 cGy in 180 cGy fractions including a scheduled 10 day break. Following the break, the patient's treatment was replanned at which the initial treatment volume was reduced by 50.9% for the duration of the treatment course. Radiation Therapy Oncology Group (RTOG) grade III pneumonitis developed which was managed medically. Neither disease progression nor late effects have occurred. The use of IMRT and planned treatment break was successful in the treatment of a case of UCD, and should be considered for other unresectable cases.Keywords
This publication has 33 references indexed in Scilit:
- Intensity-Modulated Proton Therapy Further Reduces Normal Tissue Exposure During Definitive Therapy for Locally Advanced Distal Esophageal Tumors: A Dosimetric StudyInternational Journal of Radiation Oncology*Biology*Physics, 2011
- A 4D IMRT planning method using deformable image registration to improve normal tissue sparing with contemporary delivery techniquesRadiation Oncology, 2011
- Involved-Node Radiotherapy and Modern Radiation Treatment Techniques in Patients With Hodgkin LymphomaInternational Journal of Radiation Oncology*Biology*Physics, 2011
- Castleman's Disease in the Head and Neck Region: Meta-analysis of Reported Cases in Taiwan and Literature ReviewJournal of the Formosan Medical Association, 2010
- Neoadjuvant radiotherapy of primary irresectable unicentric Castleman's disease: a case report and review of the literatureRadiation Oncology, 2010
- A fully electronic intensity-modulated radiation therapy quality assurance (IMRT QA) process implemented in a network comprised of independent treatment planning, record and verify, and delivery systemsRadiology and Oncology, 2010
- Intensity modulated radiotherapy (IMRT) in bilateral retinoblastomaRadiology and Oncology, 2010
- Angiofollicular lymph node hyperplasia (Castleman's disease)Cancer Treatment Reviews, 1995
- Cellular death by apoptosis in some radiosensitive and radioresistant mammalian tissuesJournal of Theoretical Biology, 1983
- Plasma cell giant lymph node hyperplasia responding to radiation therapyAmerican Journal of Roentgenology, 1978